Govt: Remdesivir only for those on oxygen support
24.04.2021
The Union health ministry has issued an updated “clinical guidance for management of adult Covid-19 patients”, recommending emergency use authorisation of Remdesivir for patients with moderate to severe disease, requiring supplemental oxygen, within 10 days of onset of symptoms.
“Not to be used in patients who are not on oxygen support or in home settings,” the ministry underlined.
The guidelines issued by AIIMS and ICMR stated that tocilizumab may be considered in patients with significantly raised inflammatory markers and not improving despite use of steroids with there being no active bacterial/fungal/tubercular infection. They also recommended off-label use of convalescent plasma only in the early moderate disease. PTI
•Hepatitis drug gets DCGI nod for Covid use,
No comments:
Post a Comment